Stock listing

Eyepoint, Inc.

Selected listing: EYPT · NASDAQ · USD · US

Eyepoint, Inc. (NASDAQ:EYPT), Health Technology. Latest release Sep 2, 2026: EyePoint Announces Participation at Upcoming Investor Conferences and Scientific…

EYPT:NASDAQUSDUSUpdated October 2, 2026

Ticker: NASDAQ:EYPT
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: NASDAQ
Currency: USD

About Eyepoint, Inc.

Eyepoint, Inc. is a public company traded under the ticker EYPT in the American market. Eyepoint focuses on developing innovative therapeutics for eye diseases, aiming to improve patient outcomes through advanced drug delivery systems.

Latest news from Eyepoint, Inc.

EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting

September 2, 2026

EyePoint Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate Developments

August 5, 2026

EyePoint Completes Enrollment of Both Pivotal Phase 3 Trials of DURAVYU™ for Treatment of Diabetic Macular Edema (DME)

July 30, 2026

EyePoint Appoints Tarek S. Hassan, M.D., as Chief Strategic Science Officer

July 13, 2026

EyePoint Announces Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU™, Building Confidence Ahead of Mid-2026 Topline Data

May 13, 2026

All Eyepoint, Inc. news →

Events

Replays

EyePoint, Inc. (EYPT) Q1 2026 Earnings Call
Wed, May 06, 2026 · 08:30 AM ET
Watch
EyePoint, Inc. (EYPT) Q4 2025 Earnings Call
Wed, Mar 04, 2026 · 08:30 AM ET
Watch
EyePoint, Inc. (EYPT) Q3 2025 Earnings Call
Wed, Nov 05, 2025 · 08:30 AM ET
Watch

Research Eyepoint, Inc.

Eyepoint, Inc. company profile

View the public company page for Eyepoint, Inc. on 6ix.

Eyepoint, Inc. news

Read company news and market updates connected to Eyepoint, Inc..

Eyepoint, Inc. investor events

Find investor webinars, events, and replay context for Eyepoint, Inc..